____the DEA master Pharmacy Plan 15DDHQ20R00000021, 9/20/2020, by Amanda Vanderveen, (1)
” Yes, we would expect that pharmacies that have an established mechanism to expose their business data to be incorporated with the provided data. “
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, JOSEPH SOLVO ESQ., REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., WILLIE GUINYARD BS., BRAHM FISHER ESQ., JOSEPH WEBSTER MD., ESTER HYATT PHD., BRAHM FISHER ESQ., MICHELE ALEXANDER, CUDJOE WILDING BS, DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
THE CONGRESSIONAL COMMITTEES ON GOVERNMENT OPERATIONS, CONGRESSIONAL COMMITTEE ON THE JUDICIARY, THE CONGRESSIONAL COMMITTEE ON HOMELAND SECURITY, CONGRESSIONAL BLACK CAUCUS MUST BEGIN INVESTIGATIONS OF THE CORRUPTION WITHIN THE THE UNITED STATES DEPARTMENT OF DRUG ENFORCEMENT (DEA) IMMEDIATELY
WALMART PHARMACIES VS UNITED STATES DRUG ENFORCEMENT ADMINISTRATION
Case No. 4:20-cv-00817-SDJ
When a group of Black Pharmacists formed together to expose the targeting of their establishments by the DOJ/DEA, both agencies got even more clever and filed an unjustified complaint against Wal-Mart Pharmacies.
“Unfortunately, certain DOJ officials have long seemed more focused on chasing headlines than fixing the crisis. They are now threatening a completely unjustified lawsuit against Walmart, claiming in hindsight pharmacists should have refused to fill otherwise valid opioid prescriptions that were written by the very doctors that the federal government still approves to write prescriptions.”
Our group has developed strong evidence these actions were done by DOJ/DEA as a publicity stunt to disguise to the American taxpayer that their aberrant behavior is not targeted at any group particularly black pharmacy owners. DEA will argue to the Pubilc they are just doing their jobs. We of course “know better.”
BACKGROUND OF WAL-MART PHARMACIES VS DEPARTMENT OF JUSTICE AND UNITED STATES DRUG ENFORCEMENT ADMINISTRATION
WAL-MART PHARMACY PRESS RELEASE
” We are bringing this lawsuit because there is no federal law requiring pharmacists to interfere in the doctor-patient relationship to the degree DOJ is demanding, and in fact, expert federal and state health agencies routinely say it is not allowed and potentially harmful to patients with legitimate medical needs.
DOJ is forcing Walmart and our pharmacists between a rock and a hard place. At the same time that DOJ is threatening to sue Walmart for not going even further in second-guessing doctors, state health regulators are threatening Walmart and our pharmacists for going too far and interfering in the doctor-patient relationship. Doctors and patients also bring lawsuits when their opioid prescriptions are not filled.
Walmart and our pharmacists are torn between demands from DEA on one side and health agencies and regulators on the other, and patients are caught in the middle. We need a court to clarify the roles and legal responsibilities of pharmacists and pharmacies in filling opioid prescriptions.”
THE MISSION OF THE DEA
DEA’s mission is to enforce the controlled substance laws and regulations of the United States and bring to the criminal and civil justice system of the United States, or any other competent jurisdiction, those organizations and principal members of organizations involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States; and to recommend and support non-enforcement programs aimed at reducing the availability of illicit controlled substances on the domestic and international markets.
Regulatory enforcement by DEA will focus on DEA required records, the security of controlled substances, and the “Due Diligence” placed on a registrant to know their customers. Failure to maintain complete and accurate records, inventory, the security of controlled substances, and the lack of a “Due Diligence” program may result in administrative and civil actions on their DEA registration. (2)
EXPOSING DEA’S FRAUDULENT METHODOLOGIES AND WHY WALMART SHOULD NOT SETTLE
Notably, DEA’s evidence always relies upon exaggerations on numbers of “pills” and street language such as “pill mills,” “Holy Grails,” and “Cocktails,” not on medical disease states, clinical conditions, or medical terminology. Prosecutors have found these forms of distortion, redefinition of medical procedures effectively sells juries. Further, Judges often instruct the juries to ignore any clinical presentation or will not allow such testimony on the record.
The actions of the DOJ/DEA are Federal Government overreach and the attorney representing companies like Walmart, CVS Purdue Pharma do a tremendous disservice to small family-owned pharmacies and to the taxpayers when they enter into settlements with the DOJ/DEA. Our answer is even more clear, don’t settle!
CONGRESS MUST INVESTIGATE
DISBANDING THE DEA
When understanding the level of corruption of the DEA and why this Federal Agency must be disbanded, defunded, or redirected out of medicine, One needs only to ask themselves two fundamental questions.
A. How long has the DEA been around?
B. How long have pain and anxiety been around?
The DEA has gained power in 3 ways:
1 . Through its Kangaroo Court System, which is permitted to operate outside the Rules of Federal Evidence and Civil Procedures.
2. Through threats and intimidation and using forfeiture clauses, the DEA has managed to muscle their way into the Medical/Dental/Pharmacy professions until they have literally redefined, reinterpreted medical procedures/ protocols and have criminalized them. (examples include terms such as addiction and dependency)
3. Through the use of Junk Science, the DEA has been waging a clandestine campaign of disinformation to sway the public into believing prescribed narcotic analgesic medications are indeed dangerous drugs and their high dosages are red flags indicating abuse and trafficking which have contributed to the so-called opioid crisis around America. (12)
In fact, DEA is the single most heinous government agency whose tactics have increased the cost of medication and healthcare all across America by misinterpreting the purpose and roles of medications needed to treat acute, chronic, neuropathic, and psychological pain.
Healthcare Providers are assumed by DEA to be lacking due diligence if they don’t prove beyond a shadow of a doubt that they have addressed any red flags, but in DEA court tribunals the agencies hardly ever produce evidence of real diversion. They rely on suspicions and glitzy non-scientific presentations. (13)
Let it also be noted, patients being treated for chronic pain who travel to a Black-owned pharmacy are called “RED FLAGS” by the DEA and these pharmacies are classified as imminent dangers to the “Public Health.” While the same patients traveling to non-black owned pharmacies, with the same prescriptions, using the exact same payment methodology, the fictitious label of “red flags” does not truly exist.
“AND THE LORD SAID UNTO PAUL DO NOT BE AFRAID FOR I AM WITH YOU”
THE DEA PHARMACY EXPERT
“FALSUS IN UNO, FALSUS IN OMNIBUS”
The DEA and the United States Department of Justice have relied upon a cadre of pharmacy experts such as Dr. Sullivan, Tracey Gordon PharmD, whose analysis and methodologies are questionable, anecdotal, and seriously flawed. Oftentimes their review, which is an analysis of a patient’s medical records doesn’t capture sufficient information to conclusively establish the illegitimacy of a prescribing practitioner’s reasoning for issuing a specific prescription to a patient for a specific disease state. (6)
In many cases, the pharmacy experts don’t often have the full patient’s record because the DEA Diversion Investigator never obtains them, and almost never consults with the treating medical practitioner or fails to conduct a thorough investigation.
It is further noted that one can easily find these flaws being committed by so-called pharmacy experts, like Don Sullivan and Tracey Gordon. These experts and flaws are found in nearly the entire DEA’s case files over the past 20 years. This has resulted in thousands of pharmacists, small pharmacy owners, and large pharmacy chains being subjected to extortion through fines, and may lead to consequences of which pharmacists and physicians can lose their licenses/property, serve liberty and cause patients committing suicide. (7)
DALE SISCO, ESQ, LAW TAMPA, FLORIDA EXPOSED THE DECEPTIVE MOTIVATION OF A DEA PHARMACY EXPERT ROBERT B J DORION PHARMD
Robert BJ Dorion was once hailed as a renowned DEA Pharmacist expert, testifying on behalf of the Government (DEA) against partitioners in both Civil and Criminal court proceedings. Dorion was noted for use of the terms “red flags”, and “corresponding responsibility.” However, his court credibility became questionable after the below statements he iterated to Tampa defense Attorney Dale Sisco.
Robert B J Dorion:
To get back to your practical question…..Then who is correct in the eyes of the law…… You have to demonstrate as an expert witness that you have taken the means and are knowledgeable in whatever you are promoting…… Whether it’s a conclusion…… Or a method that you have adopted to arrive at that conclusion.
Robert B J Dorion:
You will be cross-examined critically
Robert B J Dorion:
That’s where you may buckle and fold unless you can demonstrate that you are competent
Robert B J Dorion:
So it’s not a question of the law………. It’s a question of convincing the judge (or the jury)
THE CONGRESS MUST INVESTIGATE AND DEFUND THE UNITED STATES DRUG ENFORCEMENT AGENCY (DEA)
DEA’S EXPERT TWINS OF DECEPTION
“FALSUS IN UNO, FALSUS IN OMNIBUS”
They’ve (DEA) exploited the use of a network of medical practitioner hustlers such as Donald Sullivan RPh., PhD., Timothy Munzing, MD., in courtrooms who have been well paid by the Government. See GovTribe. (1),(2),(3) Their testimony often relies on tacit bias without examining radiographs (X-rays) of the patients or interviewing prescribing practitioners. In many cases, it is equivalent to the discredited bite mark evidence once used in courtrooms.
AMERICA WE ARE BETTER THAN THIS!!
The DOJ, DEA idea is to starve us out of business through harassment, intimidation, and fraudulent misrepresentations by their network of so-called DEA experts like Timothy Munzing, MD. (1)
According to GovTribe, a website that tracks payments to federal contractors, Munzing is paid $300 an hour by the DEA. (1) In the past few months, Munzing has been paid over $250,000 by the DEA to review patient records and testify as an expert witness in DEA cases. (1)
AMERICA WE ARE BETTER THAN THIS!!
Dr. Munzing who works with Kaiser Permanente and Donald R. Sulivan, Professor at Ohio State University College of Pharmacy never appears to have examined or interviewed the patients or prescribing physicians and relied on conclusions of Junk Science in their courtroom testimonies.
JACK FOLSON RPH
CLINICAL PHARMACIST EXPERT IN PHARMACY PRACTICE: HOSPITAL, RETAIL CHAIN, RETAIL INDEPENDENT, STERILE COMPOUNDING, NON-STERILE COMPOUNDING, FORMER DIRECTOR OF PHARMACY.
DEA DIVERSION OF THE TRUTH
“As it pertains to corresponding responsibility we do not have primary responsibility and this is because we do not have the training in diagnostics that would be required to proffer a second opinion.”(4)(12)
Once a diagnosis is given, the only thing that the pharmacist can do is make a recommendation as to the proper drug therapy for that particular patient, within that particular diagnosis, and at best it can only be a recommendation that lacks a full understanding of the diagnostic criteria.
To require the pharmacist to be the final arbiter of what is or is not reasonable therapy based upon inferior knowledge of diagnostics would be erroneous
Jack Folson RPh., expert pharmacist Consultant from Michigan stated in his May 2020 report known as The Folson Amicus Brief:
“Presently, because of the criminalization of pain management, suffering has increased and has led to an increase in heroin use. Due to the dangers associated with heroin, use this, more than anything else, in this case, is an immediate threat to public safety. To put it plainly, the actions by the DEA are causing the thing that they are trying to avoid.” (3),(4)
RICHARD L. WYNN, RPH, Ph.D., PROFESSOR OF PHARMACOLOGY, UNIVERSITY OF MARYLAND DENTAL SCHOOL
THE PHARMACIST ROLE
Richard L. Wynn Rph, Ph.D opins
The Pharmacist’s role is to make sure they accurately dispense what the provider request and to check for possible drug interaction. (see video)
JOSEPH L.WEBSTER, SR., MD, MBA, FACP, BS. PHARMACY
Joseph Webster MD, writes:
“Once the provider has met all of the aforementioned and other ‘requirements to write a prescription, then and then ONLY should a healthcare practitioner write a prescription. I do not see where Dr. Sullivan obtained his evidence that the pharmacist in question attempted to do any of these steps in the ‘chain of authority’ in the cases in question. Furthermore, as stated above, a pharmacist IS NOT AUTHORIZED TO WRITE A CONTROL PRESCRIPTIONS by any of the regulatory boards of health.”
“It is my professional opinion that the pharmacist in question had ‘no reason’ and more importantly the pharmacist had ‘no power’ to question or interrogate each provider on ‘each prescription’ that is received as long as the ‘safety, efficacy and convenience’ of the medications being prescribed meet the standards of Medication Dispensing. Any given medication can be and certainly will be given for multiple different diagnoses and it is not even feasible for the pharmacist to ‘contact and question’ each and every diagnosis.”
These harms to medical practitioners have occurred specifically based on these DEA so-called expert’s (like Sullivan) fraudulent analyses and methodologies. The level of DEA’s corruption and abuse has been so pernicious that the entire 20-year case files of charges against healthcare practitioners must be re-examined and convictions, fines, and sanctions reversed, overturned, and dismissed with prejudice. (4)
DEA pharmacy experts failed basic standards of care as a Pharmacist. Instead, they have engaged in a self-serving crusade of fraud, deception, billing the taxpayers of the United States of America for services they did not perform, and received payments for their ill-gotten gains.
THE MEDICAL SIDE OF THE SO CALLED OPIOD EPIDEMIC
The idea that medically prescribed opioid medications (MPOM) or narcotic analgesic medications (NAM) cannot be used for chronic pain is simply not true and is misleading. Further, the idea these medications are not to be used in combination with other medications such as those used to relieve anxiety; mood disorders, or sleep is further in error.
MPOM or NAM, when prescribed and use for long term chronic pain will result in dependency. It is therefore the role of the Pharmacist to ensure the patient who is being treated for chronic pain is properly instructed on how to use this class of medication correctly, for their safety.
These medications are safe when used correctly and like any medications control or non-control when taken beyond their therapeutic dose are dangerous and may result in death. More importantly, to this date, unless is the case of extreme anaphylaxis there is no case in the literature when any individual has succumbed to death when given a therapeutic dose. (10)
In fact, other medications may cause a higher level of mortality in therapeutic doses. Warfarin, an anticoagulant for example has an extremely narrow therapeutic index and cranial hemorrhage is somewhat common. Antibiotics, are too widely prescribed and create a need for newer and stronger antibiotics and will be the death of all humankind eventually. The CDC is well aware of these dangers. Anti-Neoplastic medications in the treatment of cancer are extremely toxic and what is considered a “cure” is remission for just 5 years.
RICHARD A. “RED” LAWHERN, PH.D
Richard A. “Red” Lawhern, Ph.D., is a non-physician patient advocate, moderator of online patient communities, and co-founder and former director of research for The Alliance for Treatment of Intractable Pain. @lawhern1 facebook.com/red.lawhern (5)
Stop persecuting doctors for legitimately prescribing opioids for chronic pain
According to Richard Lawhern, June 19, 2020 article, “STOP PERSECUTING DOCTORS FOR LEGITIMATELY PRESCRIBING OPIOIDS FOR CHRONIC PAIN” in STAT+ online news states:
The damage to healthcare providers and the chronic pain patient population is devastating and the DEA never takes into account the clinical needs of the patients. It’s as if they have criminalized pain management without the benefit of clinical knowledge. (5)
“Doctors should have gotten the message by now that deserting patients is a violation of medical practice standards, not to mention human rights. But they haven’t. On the contrary, they’ve been hearing about other doctors who got raided by Drug Enforcement Agency swat teams, their patients terrorized, medical records seized, and practices ruined by announcements in local news media. Compounding such brutal tactics, chain pharmacies have compiled high prescriber lists, blacklisting “top prescribing” physicians and denying prescription pain medication to their patients.” (5) (6)
Richard Lawhern points out;
In November, 2018, the American Medical Association’s House of Delegates issued its groundbreaking Resolution 235. It reads in part:
“… no entity should use MME (morphine milligram equivalents) thresholds as anything more than guidance, and physicians should not be subject to professional discipline, loss of board certification, loss of clinical privileges, criminal prosecution, civil liability, or other penalties or practice limitations solely for prescribing opioids at a quantitative level above the MME thresholds found in the CDC Guideline for Prescribing Opioids.”
” In April 2019, under fire from medical professionals across the country, the CDC advised against “misapplication” of the guideline. Writing in the New England Journal of Medicine, three authors of the guideline said it was never intended to become a mandated standard, even though more than 30 states had incorporated it into legislation in the three years since its publication. At about the same time, the FDA issued a safety warning against rapidly tapering individuals off opioids or suddenly stopping their administration, based on known harms to patients.“
Lawhern further writes:
“Much of the mess described by patients stems directly from the 2016 Centers for Disease Control and Prevention’s “Guideline for Prescribing Opioids for Chronic Pain.” In it, the CDC urged practitioners to avoid increasing opioid doses for new patients above daily doses of 50 morphine milligram equivalents (MME). For patients maintained on doses above 90 MME, doctors were told to conduct and document risk and benefits reviews.
“The CDC guideline became controversial almost immediately after it was published. Despite major criticism, it was widely interpreted by physicians, hospitals, insurance providers, state legislators, medical boards, and the DEA as a mandate for hard limits on prescribing opioids — even for so-called legacy patients for whom long-term or high-dose opioids had already proven safe and effective.“
“Since the publication of the guideline, the American Medical Association, the American Association of Family Physicians, and other organizations have repudiated the science, logic, and conclusions of the CDC guideline and of the DEA’s witch hunt. But nobody in government is listening to medical professionals any more than they are listening to patients.” (5),(6)
THE AMERICAN MEDICAL ASSOCIATION DEMANDS IMMEDIATE SUSPENSION OF CDC GUIDELINES
The American Medical Association wrote on June 16, 2020: (7)
“The nation no longer has a prescription opioid-driven epidemic. However, we are now facing an unprecedented, multi-factorial, and much more dangerous overdose and the drug epidemic is driven by heroin and illicitly manufactured fentanyl, fentanyl analogs, and stimulants. We can no longer afford to view increasing drug-related mortality through a prescription opioid-myopic lens. This is why the AMA continues its aggressive advocacy efforts in support of patients with pain and those with a substance use disorder as well as broad support for harm reduction policies and practices that address the wide range of factors affecting patients. “
The nation’s opioid epidemic has never been just about prescription opioids, and we encourage CDC to take a broader view of how to help ensure patients have access to evidence-based comprehensive care that includes multidisciplinary, multimodal pain care options as well as efforts to remove the stigma that patients with pain experience on a regular basis. CDC has a great opportunity to demonstrate its commitment to patients with pain through a detailed re-examination of the CDC Guideline, and the AMA urges CDC to work with physicians and patients to ensure that the revisions support patients with pain and the physicians who care for them.”
“While the AMA understands that the apparent goal of the CDC Guideline was to reduce opioid prescribing, we believe the proper role of CDC is to improve pain care. It follows that a dedicated effort must be made to undo the damage from the misapplication of the CDC Guideline.“
The AMA writes:
Accordingly, the CDC Guideline could be substantially improved in three overarching ways. First, by incorporating some fundamental revisions that acknowledge that many patients experience pain that is not well controlled, substantially impairs their quality of life and/or functional status, stigmatizes them, and could be managed with more compassionate patient care.
Second, by using the revised CDC Guideline as part of a coordinated federal strategy to help ensure patients with pain receive comprehensive care delivered in a patient-centric approach. And third, by urging state legislatures, payers, pharmacy chains, pharmacy benefit management companies, and all other stakeholders to immediately suspend the use of the CDC Guideline as an arbitrary policy to limit, discontinue or taper a patient’s opioid therapy.
The AMA further writes:
“We are concerned that such a careful approach to identifying the precise combination of pharmacologic options could be flagged on a prescription drug monitoring program as indications wrongly interpreted as so-called “doctor shopping” and cause the patient to be inappropriately questioned by a pharmacist. The AMA strongly supports a pharmacist carrying out his or her corresponding responsibility under state and federal law, but the past few years are rife with examples of patients facing what amounts to interrogations at the pharmacy counter as well as denials of legitimate medication. The AMA urges CDC to provide strong guidance and support for physicians and pharmacists to work together rather than jumping to conclusions about a patient’s PDMP report.” (7)
” Clinicians are encouraged to have open and honest discussions with their patients so as to avoid stigmatizing the decision to start, continue, or discontinue opioids or non-opioid therapy. This discussion also must account for the treatment options accessible to the patient based on their health condition, social determinants of health (e.g. transportation, employment, childcare responsibilities, race, gender, age) and insurance coverage.” (7)
JOSEPH L.WEBSTER, SR., MD, MBA, FACP, BS. PHARMACY
Joseph Webster MD, writes:
” It is statutorily the purview of the pharmacist to ‘inspect and assure’ that the drug that is being given is safe and has no known incompatibilities with the patient and its holistic environment.
According to Joseph Webster MD:
“It is not the purview nor is the pharmacist trained to ‘challenge the diagnosis’ of the physician and to do so verbally or otherwise with the patient. It erodes the ‘doctor-patient’ relationship and destroys the ‘confidence’ of the patient in his/her physician. At the very least it is ‘unethical’ and may very well be a HIPPA violation and beneath the standard of care as a pharmacist. “
CONGRESS MUST INVESTIGATE!!!
“Any healthcare provider that is licensed to ‘prescribe’ is governed by the set of conditions and circumstances under which a prescription can be written. Thus it is illegal to write a prescription for a person that the prescriber has not conducted the ‘chain of authority’ that would qualify him/her to write a prescription: history and physical examination, formulation of a diagnosis, and discussing such with the patient as well as the proposed manner of treatment in a culturally sensitive and ethically appropriate manner; and provision of an opportunity for the patient to ‘question and discuss alternative forms of treatment; etc.”
WE HAVE NO LOVE FOR THE LARGE CHAIN PHARMACY BUT!!!
Let it be clear, we have no love for Walmart and the other large chain pharmacies but there is an injustice being done to Walmart and the other large chains which affect us all.
Pronto Pharmacy is a small family-run business and often times we are excluded from many insurance plans who contract with large chain pharmacies. More importantly, insurances simply don’t pay their bills to the small family-owned pharmacy. Simply put they cheat us with extraordinary fee attachments.
DEA/DOJ PRACTICE OF EXTORTION OF WALMART, LARGE CHAIN PHARMACIES, AND DRUG MANUFACTURERS
However, the large chain pharmacies and their parent companies clearly violate laws through false billings and even forged prescriptions on their part, while the DEA collects billions of dollars in what amounts to “extortion fines” and the large chains are given a pass. These warnings remain ever so obliterated, and one cannot ignore the functions of how race works in these types of proceedings.
Most noticeable, the chain pharmacies (CVS, Walgreens) are now owners of the drug insurance companies. So they now own the Market, the Pricing, and who plays in their market, and who is excluded. The problem is so extensive, Walmart had to lay-off 40% of its pharmacy staff around the country in part because of a dispute with CVS CAREMARK over reimbursements. (9)
PRECONCEIVED AS ARROGANT
DEA: THE CRIMES OF A BLACK-OWNED PHARMACY, PUNISHED FOR PAYMENT OF THEIR SERVICES
Black-owned pharmacies are punished by DOJ/DEA for being paid for their services they render to their patients. Once again it cannot be ignored how race is used in the decision-making process to target or ignore the economic (stratification) injuries when Black healthcare providers are reimbursed by third-party insurance payers differently based solely on zip codes. This is precisely why an increasing number of medical/dental/pharmacy providers are electing to do business solely in cash, credit cards, or debits to ensure their healthcare practices can sustain economic stability. (12)
THE AMAZING DOUBLE STANDARDS
However, DEA’S actions are fraudulent while the Black-owned pharmacies who become victims, can only helplessly watch the very patients who have been tagged as red flags. These red flags will have the same prescription(s), from the same prescriber, using the same payment methodology, filled at a non-black owned pharmacy and the DEA says nothing. This is an amazing double standard. The DEA’s intent appears to reflect the mindsets of its creators like “Richard M. Nixon, President of The United States” to destroy Black Society along with Blacks owning pharmacies. (11)
Yet, the United States Drug Enforcement Agency (DEA) will prosecute black pharmacists and black-owned pharmacies for accepting cash as a form of payment. (12)(11). The problem here directly falls on the incompetence of the DEA and their private vendors (Appriss Health) who have failed to develop the software of the Prescription Drug Monitoring Program (PDMP) which can distinguish when a person pays in cash, credit card, or debit cards.
TRAPPED IN THE PURGATORY
These pharmacists are then perceived and classified as arrogant, uppidty, public health threats, imminent dangers, trapped in the purgatory of someones else’s definition of who they are and who they should be. Their certificate of control registration gets suspended for allegedly ignoring red flags in filling legally prescribed narcotic analgesic medications. (14)
Norman J Clement, Aaron Howard, Rick Fertil demand the return of our DEA pharmacy Control Substance Registrations Immediately.
FOR NOW YOU ARE WITHIN THE NORMS
- DEA Master Plan to unmask patient private healthcare data for every person receiving a prescription within 3 days: https://static1.squarespace.com/static/54d50ceee4b05797b34869cf/t/5fac5d699a1aef48f6f43d39/1605131626625/DEA+RFP+amendment.pdf
2. Practicing Pharmacy Wile Black, Norman J Clement, Beres Muschett, Debra Lynn Shephed, et all
____” when we feel a pang of shock and resentment, a personal wounding Absence of unfairness and perhaps even shame at our discomfort upon seeing someone from a marginalized group in a job or a car or house or college or appointment more prestigious than we have been led to expect when we assume that the senior citizen should be playing Parcheesi rather than developing software,”
_____” we are reflecting the efficient encoding of caste, the subconscious recognition that the person has stepped out of his or her assumed place in our society. We are responding to our embedded instructions of who should be where and who should be doing what, the breaching of the structure and boundaries that are the hallmarks of caste.”
Yet, we have further and properly been schooled by our ancestors, teachers, professors, within our hairdressers, and barbershops to resist, to not ever accept or yield to subordination. We know that the built-in institution of racial caste injustice, particularly within the Judicial System or in the fields of medical science, sports, politics, or the military. will default to all knowledgeable, educated Black persons as arrogant and uppity.
We especially observe and experience these attitudes of ill will in our history, particularly in the United States, when one is right and dares to challenge these societal mores.
6. Richard A. “Red” Lawhern, Ph.D., is a non-physician patient advocate, moderator of online patient communities, and co-founder and former director of research for The Alliance for Treatment of Intractable Pain.
7. AMERICAN MEDICAL ASSOCIATION JUNE 16, 2020, https://searchlf.ama-assn.org/undefined/documentDownload?uri=%2Funstructured%2Fbinary%2Fletter%2FLETTERS%2F2020-6-16-Letter-to-Dowell-re-Opioid-Rx-Guideline.pdf
8. Drug Policy Alliance: Its time to Dismantle the DEAhttps://www.drugpolicy.org/DEA
9. Richard Wynn, PhD, is a nationally recognized speaker, author, columnist and consultant relative to dental drug therapeutics and drug information for the dental professional. He keeps the profession informed about current issues relative to drugs in dentistry including new therapeutic agents, new drug interactions and newly reported adverse reactions in dental patients. He researches the literature daily for new reports which would be of interest to the profession. Dental schools which have provided support for his update courses have included U Mississippi, Loma Linda, UCLA, UCSF, U Washington, U Minnesota, U Pittsburgh and U Florida. State dental and dental hygiene associations providing support have included Maryland, Arkansas, Florida, Pennsylvania, Mississippi and California. Professional associations supporting Dick in his efforts include the American Dental Association and the Academy of General Dentistry. He is the lead author of the most recognized chairside dental drug reference book entitled Drug Information Handbook for Dentistry now in its 9th edition, avaliable in print and electronic formats. Dick continues to be the “source for dental drug information” because of his academic interests and his ready access to commercial, private and governmental drug data bases.
14. Caste: The Origins of Our Discontents, April 2020, pg. 47, pg. 50, pg. 72, pg. 116-117, Wilkerson, Isabelwilkerson.com